Quick Answer
BOSTON SCIENTIFIC CORP reported Total Revenue of $20.07 billion for fiscal year 2025.
BOSTON SCIENTIFIC CORP — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $20.07B +19.9% |
$16.75B +17.6% |
$14.24B +12.3% |
$12.68B +6.7% |
$11.89B +19.9% |
$9.91B -7.7% |
| Revenue (ASC 606) | $20.07B +19.9% |
$16.75B +17.6% |
$14.24B +12.3% |
$12.68B +6.7% |
$11.89B +19.9% |
$9.91B -7.7% |
| Diluted EPS | $1.94 +55.2% |
$1.25 +16.8% |
$1.07 +137.8% |
$0.45 -34.8% |
$0.69 +962.5% |
-$0.08 -102.4% |
| Total Assets | $43.67B +10.9% |
$39.40B +12.1% |
$35.14B +8.2% |
$32.47B +0.7% |
$32.23B +4.7% |
$30.78B +0.7% |
| Cash and Equivalents | $1.97B +374.6% |
$414.00M -52.1% |
$865.00M -6.8% |
$928.00M -51.8% |
$1.93B +11.0% |
$1.73B +699.1% |
| Stockholders Equity | $24.23B +11.3% |
$21.77B +12.9% |
$19.28B +9.7% |
$17.57B +5.7% |
$16.62B +8.5% |
$15.33B +10.4% |
| Operating Income | $3.61B +38.8% |
$2.60B +11.1% |
$2.34B +42.1% |
$1.65B +37.5% |
$1.20B +1598.8% |
-$80.00M -105.3% |
| Gross Profit | $13.85B +20.6% |
$11.49B +16.1% |
$9.90B +13.4% |
$8.73B +6.7% |
$8.18B +26.8% |
$6.45B -15.4% |
| Shares Outstanding | — | — | — | — | — | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $5.07B | +20.3% | +0.1% |
| Revenue (ASC 606) | September 30, 2025 | $5.07B | +20.3% | +0.1% |
| Diluted EPS | September 30, 2025 | $0.51 | +59.4% | -3.8% |
| Total Assets | September 30, 2025 | $42.71B | +12.2% | +2.8% |
| Cash and Equivalents | September 30, 2025 | $1.27B | -49.0% | +138.8% |
| Stockholders Equity | September 30, 2025 | $23.39B | +13.0% | +4.4% |
| Operating Income | September 30, 2025 | $1.05B | +43.0% | +28.0% |
| Gross Profit | September 30, 2025 | $3.54B | +22.3% | +3.4% |
| Shares Outstanding | March 31, 2020 | 1.40B | +0.6% | +0.3% |
- BOSTON SCIENTIFIC CORP reported Total Revenue of $20.07 billion for fiscal year 2025.
- BOSTON SCIENTIFIC CORP showed an increase of +19.9% in Total Revenue compared to the prior fiscal year.
- BOSTON SCIENTIFIC CORP reported Revenue (ASC 606) of $20.07 billion for fiscal year 2025.
- BOSTON SCIENTIFIC CORP showed an increase of +19.9% in Revenue (ASC 606) compared to the prior fiscal year.
- BOSTON SCIENTIFIC CORP reported Diluted EPS of $1.94 per share for fiscal year 2025.
- BOSTON SCIENTIFIC CORP showed an increase of +55.2% in Diluted EPS compared to the prior fiscal year.
- BOSTON SCIENTIFIC CORP reported Total Assets of $43.67 billion for fiscal year 2025.
- BOSTON SCIENTIFIC CORP showed an increase of +10.9% in Total Assets compared to the prior fiscal year.
- BOSTON SCIENTIFIC CORP reported Cash and Equivalents of $1.97 billion for fiscal year 2025.
- BOSTON SCIENTIFIC CORP showed an increase of +374.6% in Cash and Equivalents compared to the prior fiscal year.
- BOSTON SCIENTIFIC CORP reported Stockholders Equity of $24.23 billion for fiscal year 2025.
- BOSTON SCIENTIFIC CORP showed an increase of +11.3% in Stockholders Equity compared to the prior fiscal year.
- BOSTON SCIENTIFIC CORP reported Operating Income of $3.61 billion for fiscal year 2025.
- BOSTON SCIENTIFIC CORP showed an increase of +38.8% in Operating Income compared to the prior fiscal year.
- BOSTON SCIENTIFIC CORP reported Gross Profit of $13.85 billion for fiscal year 2025.
- BOSTON SCIENTIFIC CORP showed an increase of +20.6% in Gross Profit compared to the prior fiscal year.
- BOSTON SCIENTIFIC CORP reported Shares Outstanding of 1.39 billion shares for fiscal year 2019.
- BOSTON SCIENTIFIC CORP showed an increase of +0.7% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: